Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. - Wikidata - awgldk - TriplyDB

Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.

Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.

http://www.wikidata.org/entity/Q35024144

about

Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies TRIM family proteins and their emerging roles in innate immunity Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1 Respiratory syncytial virus matrix protein induces lung epithelial cell cycle arrest through a p53 dependent pathway Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.SUMOylation promotes PML degradation during encephalomyocarditis virus infection.Microarray analysis revealing common and distinct functions of promyelocytic leukemia protein (PML) and tumor necrosis factor alpha (TNFα) signaling in endothelial cells.Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells Transcriptional role of p53 in interferon-mediated antiviral immunity.p53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling.Implication of PMLIV in both intrinsic and innate immunity.Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals?PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx Post-translational modifications of PML: consequences and implications.Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression p53 Is a Host Cell Regulator during Herpes Simplex Encephalitis.Roles of p53 in herpes simplex virus 1 replication.Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1 Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication.Emerging roles of p53 and other tumour-suppressor genes in immune regulation Identification of two p53 isoforms from Litopenaeus vannamei and their interaction with NF-κB to induce distinct immune response.Macrophages, inflammation, and tumor suppressors: ARF, a new player in the game.Differential Roles of PML Isoforms.Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death Sumo and the cellular stress response.Dual Role of p53 in Innate Antiviral Immunity.Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.Interactions between viral and prokaryotic pathogens in a mixed infection with cardiovirus and mycoplasma.The eIF2alpha kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53.Alterations of Nuclear Architecture and Epigenetic Signatures during African Swine Fever Virus Infection.MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.[Implication of PML nuclear bodies in intrinsic and innate immunity].Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints.Resistance to rabies virus infection conferred by the PMLIV isoform.

P2860

Q24293202-5A3B9E19-F72F-424A-8F4B-1858B33ECB54 Q24302645-48CE2068-6F16-47FD-B9B1-10CE4FF7D215 Q24607229-2DC48C05-42D6-4BEA-A891-30CF84208B76 Q26825450-6D7B7B74-C031-4073-9665-89CF4E4BF317 Q27027918-23555C3E-F85B-4C47-8865-153444C85567 Q28729205-D78F34E8-2043-40F6-B9BF-BAEC03297228 Q28821775-CB95AE90-F053-4D02-948A-963C8726CB9D Q34190751-642899FA-C91B-4543-B130-61CFADB65218 Q34295991-719566F5-D526-4D25-93AF-A7B17841DFD0 Q34402748-A5A7A887-BF6D-4FA8-B8E0-B9C907E5F1FC Q34427740-2D89297C-2992-49D9-8F82-5CBB5A9AC7DE Q34551874-FA2FA61C-9894-46CD-A55D-26500537658F Q34802156-BF771472-875E-4711-8C89-E74DF06FED2F Q35048996-C21FDD7D-F4BF-4BEA-ABB8-2D7D9ACD4AEA Q35105677-FD9E956C-CE7C-428B-8E87-B9759255780B Q35808644-755192FF-1512-4452-9553-D18F372A1B7F Q35840895-450995E3-AAB5-4345-9555-7CAF8DE8E5FF Q36516772-AD77455F-0117-4E1D-8169-02AC791726A1 Q36804608-CC9C9BD2-5B38-4EBF-A52A-76EB6868BBDF Q37093496-19208293-6399-496F-99C1-CAE78B098C26 Q37123340-00D3A2CB-597B-47AD-AACB-A8936A36AE26 Q37166304-0AAE514E-2521-4DCA-9833-9C8E21DDC0C9 Q37258617-A9CFE7BE-2D1D-4494-B52C-FEB526A70D45 Q37547441-CA8A668F-2E4A-40BA-957A-D643CD35CC24 Q37666015-427C6221-4904-43F2-9AEC-78CA0D07DEBE Q37731374-6BAF5108-0C46-4777-939C-70E64DDC971D Q38073753-E614F873-4619-4178-92D6-2DBC89267443 Q38111771-A2A0D9E2-B21A-46FA-A7A2-98B80EF3C39E Q38244749-31C6C571-0F92-4B96-B495-1ECE3FDD7D5E Q38535130-2EB736F7-7C89-4959-A243-9936E40F30E9 Q38613932-A7888944-7F6D-400A-9C80-A470A0820B74 Q38698793-CA533C47-2CFB-4549-AED6-AB8F416FC665 Q38716767-015C84BF-3350-4CA1-995E-A6BB430DFFD3 Q39824944-44A9208F-E392-46E1-A829-E69C4796345E Q40085524-F897D256-432D-42F2-95A1-05A1F1DADDBD Q40138443-0DE3BB7F-0AC5-4014-913D-70598E09201D Q40677893-F0FCE488-39C3-46BD-8879-F312CE8473B8 Q41760127-971B659F-8A9A-41A3-9284-F8D2AD68772F Q42121608-D42486AF-C8C3-426E-9391-22C1AF4D8A2F Q42413574-A21CB781-4013-49D8-B56A-5248B6ED9308

P2860

Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.

http://www.wikidata.org/entity/Q35024144

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Cross talk between PML and p53 ...... cations for antiviral defense.

@ast

Cross talk between PML and p53 ...... cations for antiviral defense.

@en

type

label

Cross talk between PML and p53 ...... cations for antiviral defense.

@ast

Cross talk between PML and p53 ...... cations for antiviral defense.

@en

prefLabel

Cross talk between PML and p53 ...... cations for antiviral defense.

@ast

Cross talk between PML and p53 ...... cations for antiviral defense.

@en

P1433

Q35024144-0E572987-18F3-4261-B80A-FF05B48574FC

P1476

Q35024144-9F1F2D45-6409-44A4-88D4-7CB35AB99CCC

P2093

Q35024144-319022A4-8A4C-469B-8877-67D73F21CC33

Q35024144-65221AFA-9B74-4473-AF34-D4A79E9F01AF

Q35024144-8E627306-FE25-4395-A0EC-09A3D4EC4C24

P2860

Q35024144-07BDBB32-A318-4070-9A71-8FB2D045898B

Q35024144-08037341-515A-42A0-A156-5D282A179170

Q35024144-0DC8E71F-24A5-4B1A-8120-A98B4DAD1664

Q35024144-0DF3B901-52AB-4A47-BB4F-442C8EC3BA8A

Q35024144-15FD8501-52E0-48CD-BFD6-2EA2E6D26F19

Q35024144-1FD231E1-FD51-49B5-B39C-8FC78A96180D

Q35024144-218F90F8-6291-4F1B-B454-BE78AD7E9C79

Q35024144-2A489553-186B-4F0D-AB7E-5115621E4F0F

Q35024144-355B7E24-BCFE-418C-83CF-1D05B21B143F

Q35024144-42525B4C-82A4-48BE-832A-69D64FE796D9

P304

Q35024144-44A14896-584B-435A-9380-22F982EDD65B

P31

Q35024144-2144A507-E6FE-45FF-807E-1F8A96FBD4EE

P356

Q35024144-1A1F2D97-4724-462E-BCF5-374AD7D4CAAB

P407

Q35024144-36A9EA29-5BD2-4B38-95FF-2F388A16D38F

P433

Q35024144-1BCD85E3-F400-4BB7-8A68-9FF9AB99168B

P478

Q35024144-B2D2E64E-462E-4F47-904C-8F93551958FF

P50

Q35024144-34CEE5FE-4E28-408B-8674-C29340DAE9F6

Q35024144-D21D478D-DDAF-490C-BC98-7C03B4280B9C

P577

Q35024144-6617837F-B83A-4EA7-BFD1-09461CAE5492

P5875

Q35024144-75792E2D-5F72-4D4D-A074-2908D51A54E6

P698

Q35024144-AFD78F78-5822-4330-9433-6D10A8A9B072

P932

Q35024144-01375E98-7987-4725-9468-026E7E7331A5

P356

P1433

Journal of Virology

P1476

Cross talk between PML and p53 ...... cations for antiviral defense.

@en

P2093

Bruno Blondel

http://www.w3.org/2001/XMLSchema#string

Mathieu Pampin

http://www.w3.org/2001/XMLSchema#string

Mounira K Chelbi-Alix

http://www.w3.org/2001/XMLSchema#string

P2860

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

Regulation of p53 activity in nuclear bodies by a specific PML isoform

Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells

Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1

Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption

Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

Role of PML and the PML-nuclear body in the control of programmed cell death

PML protein isoforms and the RBCC/TRIM motif

P304

8582-8592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00031-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

Yannick Simonin

Yann Percherancier

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6875917

http://www.w3.org/2001/XMLSchema#string

P698

16912307

http://www.w3.org/2001/XMLSchema#string

P932

1563870

http://www.w3.org/2001/XMLSchema#string